Mainz Biomed B.V. Statistics Share Statistics Mainz Biomed B.V. has 3.81M
shares outstanding. The number of shares has increased by -82.57%
in one year.
Shares Outstanding 3.81M Shares Change (YoY) -82.57% Shares Change (QoQ) 71.72% Owned by Institutions (%) 1.03% Shares Floating 4.42M Failed to Deliver (FTD) Shares 2,300 FTD / Avg. Volume 1.52%
Short Selling Information The latest short interest is 59.78K, so 1.57% of the outstanding
shares have been sold short.
Short Interest 59.78K Short % of Shares Out 1.57% Short % of Float 1.59% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.19 and the forward
PE ratio is -0.76.
Mainz Biomed B.V.'s PEG ratio is
0.
PE Ratio -0.19 Forward PE -0.76 PS Ratio 4.68 Forward PS 5.9 PB Ratio 0.69 P/FCF Ratio -0.24 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Mainz Biomed B.V..
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.32,
with a Debt / Equity ratio of 0.54.
Current Ratio 1.32 Quick Ratio 1.26 Debt / Equity 0.54 Debt / EBITDA -0.17 Debt / FCF -0.19 Interest Coverage -17.39
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $47.05K Profits Per Employee $-1.14M Employee Count 19 Asset Turnover 0.07 Inventory Turnover 0.86
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -88.94% in the
last 52 weeks. The beta is 0.25, so Mainz Biomed B.V.'s
price volatility has been higher than the market average.
Beta 0.25 52-Week Price Change -88.94% 50-Day Moving Average 1.74 200-Day Moving Average 4.57 Relative Strength Index (RSI) 38.24 Average Volume (20 Days) 151,137
Income Statement In the last 12 months, Mainz Biomed B.V. had revenue of 893.99K
and earned -21.65M
in profits. Earnings per share was -22.36.
Revenue 893.99K Gross Profit 574.88K Operating Income -18.7M Net Income -21.65M EBITDA -19.56M EBIT -20.58M Earnings Per Share (EPS) -22.36
Full Income Statement Balance Sheet The company has 6.24M in cash and 3.27M in
debt, giving a net cash position of 2.96M.
Cash & Cash Equivalents 6.24M Total Debt 3.27M Net Cash 2.96M Retained Earnings -90.98M Total Assets 13.24M Working Capital 1.89M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -17.09M
and capital expenditures -254.95K, giving a free cash flow of -17.34M.
Operating Cash Flow -17.09M Capital Expenditures -254.95K Free Cash Flow -17.34M FCF Per Share -17.91
Full Cash Flow Statement Margins Gross margin is 64.31%, with operating and profit margins of -2091.23% and -2421.8%.
Gross Margin 64.31% Operating Margin -2091.23% Pretax Margin -2421.8% Profit Margin -2421.8% EBITDA Margin -2187.76% EBIT Margin -2091.23% FCF Margin -1940.17%
Dividends & Yields MYNZ does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for MYNZ is $14,
which is 839.6% higher than the current price. The consensus rating is "Hold".
Price Target $14 Price Target Difference 839.6% Analyst Consensus Hold Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 3, 2024. It was a
backward
split with a ratio of 1:40.
Last Split Date Dec 3, 2024 Split Type backward Split Ratio 1:40
Scores Altman Z-Score -18.42 Piotroski F-Score 4
